Perdita Tweet - it’s Avacta23 Nov 2020 02:52
Yes, the have registered the affidx dx trademark for flu and covid.
AffiRX, the reagents are the affirmers.
They are being used on the LFD and BAMs.
LFD doesn’t do covid, BAMs does.
BAMs also does mutations.
Avacta confirmed in the programme, exact same timing as bid stats contract and perdita tweet
Avacta follow perdita too. How funny....
Sorry you are out amateur, time to pay the piper.